Skip to main content
. 2020 Jun 5;22(6):e15845. doi: 10.2196/15845

Table 4.

Dose-response in imputed primary outcome at posttreatment and along the follow-up.

Interventions Pretreatment to posttreatment Pretreatment to posttreatment Pretreatment to posttreatment

βa (95% CI) P value β (95% CI) P value β (95% CI) P value
HLPb

CACEc analysisd –3.32 (4.43 to –2.21) .004 e –0.51 (2.03 to 1.02) .74 –1.03 (2.61 to 0.56) .52

Effect per session –0.28 (0.34 to –0.21) .001 –0.17 (0.25 to –0.09) .03 –0.06 (0.13 to 0.02) .45
MPf

CACE analysis 0.93 (0.71 to 2.57) .57 1.01 (0.72 to 2.74) .56 1.13 (0.5 to 2.76) .49

Effect per session 0.26 (0.22 to 0.74) .59 –0.17 (0.25 to –0.09) .03 –0.06 (0.13 to 0.02) .45
PAPPg

CACE analysis 0.24 (1.30 to 1.78) .88 0.96 (0.66 to 2.57) .56 0.30 (1.24 to 1.84) .85

Effect per session –0.28 (0.34 to –0.21) .001 –0.17 (0.25 to –0.09) .03 –0.06 (0.13 to 0.02) .45
All

CACE analysis –2.11 (2.86 to –1.36) .006 –0.49 (1.37 to 0.4) .58 –0.22 (1.04 to 0.6) .79

Effect per session –0.28 (0.34 to –0.21) .001 –0.17 (0.25 to –0.09) .03 –0.06 (0.13 to 0.02) .45

aβ: regression coefficients.

bHLP: healthy lifestyle program.

cCACE: Complier Average Causal Effect.

dCompliance as attendance >4 modules.

eStatistically significant values (P<.05) are shown in italics.

fMP: mindfulness program.

gPAPP: positive affect promotion program..